Indeed, it has been reported that breast cancer patients whose tumors express high IFN response genes are 1.7 times more likely to develop metastasis and to die as a result of the disease as compared with patients whose tumors express low levels of the IFN response gene signature [36]. The gene discussed is IFNA1; the disease is breast cancer.